The tetracyclic dilithio-Si,Si'-oxo-bridged bis(N,N'-methylsilyl-beta-diketiminates) 2 and 3, having an outer LiNCCCNLiNCCCN macrocycle, were prepared from [Li{CH(SiMe(3))SiMe(OMe)(2)}](infinity) and 2 PhCN. They differ in that the substituent at the beta-C atom of each diketiminato ligand is either SiMe(3) (2) or H (3). Each of and has (i) a central Si-O-Si unit, (ii) an Si(Me) fragment N,N'-intramolecularly bridging each beta-diketiminate, and (iii) an Li(thf)(2) moiety N,N'-intermolecularly bridging the two beta-diketiminates (thf = tetrahydrofuran). Treatment of [Li{CH(SiMe(3))(SiMe(2)OMe)}](8) with 2Me(2)C(CN)(2) yielded the amorphous [Li{Si(Me)(2)((NCR)(2)CH)}](n) [R = C(Me)(2)CN] (4). From [Li{N(SiMe(3))C(Bu(t))C(H)SiMe(3)}](2) (A) and 1,3- or 1,4-C(6)H(4)(CN)(2), with no apparent synergy between the two CN groups, the product was the appropriate (mu-C(6)H(4))-bis(lithium beta-diketiminate) 6 or 7. Reaction of [Li{N(SiMe(3))C(Ph)=C(H)SiMe(3)}(tmeda)] and 1,3-C(6)H(4)(CN)(2) afforded 1,3-C(6)H(4)(X)X' (X =CC(Ph)N(SiMe3)Li(tmeda)N(SiMe3)CH; X' = CN(SiMe3)Li(tmeda)NC(Ph)=C(H)SiMe3)(9). Interaction of A and 2[1,2-C(6)H(4)(CN)(2)] gave the bis(lithio-isoindoline) derivative [C6H4C(=NH)N{Li(OEt2)}C=C(SiMe3)C(Bu(t))=N(SiMe3)]2 (5). The X-ray structures of 2, 3, 5 and 9 are presented, and reaction pathways for each reaction are suggested.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/b716888h | DOI Listing |
Nanotechnology
January 2025
Qingdao University, Ningxia Road 308, Qingdao, Shandong, 266071, CHINA.
Graphitic carbon nitride (g-C3N4) has gained significant attention as a promising nonmetallic semiconductor photocatalyst due to its photochemical stability, favorable electronic properties, and efficient light absorption. Nevertheless, its practical applications are hindered by limitations such as low specific surface area, rapid recombination of photogenerated charge carriers, poor electrical conductivity, and restricted photo-response ranges. This review explores recent advancements in the synthesis, modification and application of g-C3N4 and its nanocomposites with a focus on addressing these challenges.
View Article and Find Full Text PDFJ Med Chem
January 2025
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DK-2100, Denmark.
NMDA receptor ligands have therapeutic potential in neurological and psychiatric disorders. We designed ()-3-(5-thienyl)carboxamido-2-aminopropanoic acid derivatives with nanomolar agonist potencies at NMDA receptor subtypes (GluN12/A-D). These compounds are superagonists at GluN1/2C compared to glycine and partial to full agonists at GluN1/2A and GluN1/2D but display functional antagonism at GluN1/2B due to low agonist efficacy.
View Article and Find Full Text PDFScience
January 2025
Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
Single-cell decisions made in complex environments underlie many bacterial phenomena. Image-based transcriptomics approaches offer an avenue to study such behaviors, yet these approaches have been hindered by the massive density of bacterial messenger RNA. To overcome this challenge, we combined 1000-fold volumetric expansion with multiplexed error-robust fluorescence in situ hybridization (MERFISH) to create bacterial-MERFISH.
View Article and Find Full Text PDFAndrogens are pleiotropic and play pivotal roles in the formation and variation of sexual phenotypes. We show that differences in circulating androgens between the three male mating morphs in ruff sandpipers are linked to 17-beta hydroxysteroid dehydrogenase 2 (HSD17B2), encoded by a gene within the supergene that determines the morphs. Low-testosterone males had higher expression in blood than high-testosterone males, as well as in brain areas related to social behaviors and testosterone production.
View Article and Find Full Text PDFPLOS Digit Health
January 2025
Cancer Registry of Norway, Norwegian Institute of Public health, Ullernchausseen 64, 0379 Oslo, Norway.
An external control arm based on health registry data can serve as an alternative comparator in single-arm drug development studies that lack a benchmark for comparison to the experimental treatment. However, accessing such observational healthcare data involves a lengthy and intricate application process, delaying drug approval studies and access to novel treatments. Clinical trials typically comprise only a few hundred patients usually with high-cardinality features, which makes individual data instances more exposed to re-identification attacks.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!